Functional characterization of the developmentally controlled immunoglobulin kappa 3' enhancer: regulation by Id, a repressor of helix-loop-helix transcription factors.
Open accessThe DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
We have functionally characterized an enhancer element (kappa E3') which lies 8.5 kb downstream of the immunoglobulin kappa gene. The activity of this enhancer is developmentally controlled. It is inactive at the pre-B-cell stage but active at the B-cell and plasma cell stages. This enhancer is also functional in S107 plasmacytoma cells, which lack NF-kappa B and therefore intron enhancer activity. The activity of the kappa E3' enhancer therefore provides an explanation for the transcriptional activity of endogenous kappa genes in S107 cells in the absence of intron enhancer function. We have identified a 132-bp segment of the kappa E3' enhancer that retains 75% of the activity of the entire enhancer observed in plasmacytoma cells. Within this 132-bp core, there are at least two functional elements, one of which binds to a B-cell-specific nuclear factor. This element contains a potential binding site for the B-cell- and macrophage-specific transcription factor PU.1. The kappa intron and kappa E3' enhancers were also found to be regulatable by Id, an inhibitor of helix-loop-helix transcription factors. The site of action of Id on the kappa E3' enhancer was mapped to a 25-bp region which contains a potential binding site for a helix-loop-helix transcription factor. A possible model for the developmental control of kappa gene transcription is discussed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The macrophage and B cell-specific transcription factor PU.1 is related to the ets oncogene
Klemsz, M. J., McKercher, S. R., Celada, A., Van Beveren, C., & Maki, R. A. (1990) · Cell · doi:10.1016/0092-8674(90)90219-5 · Cited by 954
The PU.1 transcription factor is the product of the putative oncogene Spi-1
Goebl, M. G. (1990) · Cell · doi:10.1016/0092-8674(90)90676-6 · Cited by 120
Cited by
Jen, Y., Weintraub, H., & Benezra, R. (1992) · Genes & Development · doi:10.1101/gad.6.8.1466 · Cited by 471
Bain, G., Engel, I., Robanus Maandag, E. C., te Riele, H. P. J., Voland, J. R., Sharp, L. L., Chun, J., Huey, B., Pinkel, D., & Murre, C. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.8.4782 · Cited by 400
Pongubala, J. M., Nagulapalli, S., Klemsz, M. J., McKercher, S. R., Maki, R. A., & Atchison, M. L. (1992) · Molecular and Cellular Biology · doi:10.1128/mcb.12.1.368 · Cited by 354
“The KE3' enhancer is much more active in a* m51 101 100 plasmacytoma cells than in pre-B cells (28, 34).”
BackgroundMethodInfluentialSelf-citationPark, K., & Atchison, M. L. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.21.9804 · Cited by 354
Self-citationRiechmann, V., van Crüchten, I., & Sablitzky, F. (1994) · Nucleic Acids Research · doi:10.1093/nar/22.5.749 · Cited by 273
Inhibition of Myeloid Differentiation by the Helix-Loop-Helix Protein Id
Kreider, B. L., Benezra, R., Rovera, G., & Kadesch, T. (1992) · Science · doi:10.1126/science.1372755 · Cited by 253
Both E12 and E47 Allow Commitment to the B Cell Lineage
Bain, G., Maandag, E. C. R., Riele, H. P. J. T., Feeney, A. J., Sheehy, A., Schlissel, M., Shinton, S. A., Hardy, R. R., & Murre, C. (1997) · Immunity · doi:10.1016/s1074-7613(00)80421-5 · Cited by 204
Eisenbeis, C. F., Singh, H., & Storb, U. (1993) · Molecular and Cellular Biology · doi:10.1128/mcb.13.10.6452-6461.1993 · Cited by 38
“1 binding sites consisted of the hexanucleotide sequence, 5'-GAGGAA-3', termed the PU box (27, 44, 48).”
BackgroundThe Igκ 3′ Enhancer Influences the Ratio of Igκ versus Igλ B Lymphocytes
Gorman, J. R., van der Stoep, N., Monroe, R., Cogne, M., Davidson, L., & Alt, F. W. (1996) · Immunity · doi:10.1016/s1074-7613(00)80319-2 · Cited by 167
PU.1 can participate in an active enhancer complex without its transcriptional activation domain
Pongubala, J. M. R., & Atchison, M. L. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.1.127 · Cited by 86
Self-citationNagulapalli, S., & Atchison, M. L. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.8.4639 · Cited by 66
Self-citationRieske, P., & Pongubala, J. R. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m007482200 · Cited by 54
Self-citationFisher, R. C., Olson, M. C., Pongubala, J. M. R., Perkel, J. M., Atchison, M. L., Scott, E. W., & Simon, M. C. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.7.4347 · Cited by 49
Self-citationHiramatsu, R., Akagi, K., Matsuoka, M., Sakumi, K., Nakamura, H., Kingsbury, L., David, C., Hardy, R. R., Yamamura, K.-I., & Sakano, H. (1995) · Cell · doi:10.1016/0092-8674(95)90138-8 · Cited by 45
Protein Acetylation Regulates Both PU.1 Transactivation and Igκ 3′ Enhancer Activity
Bai, Y., Srinivasan, L., Perkins, L., & Atchison, M. L. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.8.5160 · Cited by 39
Self-citationPongubala, J. M. R., & Atchison, M. L. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.17.10304 · Cited by 31
Self-citation
Metadata
- Authors
- Pongubala, J. M., & Atchison, M. L.
- Venue
- Molecular and Cellular Biology
- Publisher
- Informa UK Limited
- Published
- 1991-02
- Volume
- 11
- Issue
- 2
- Pages
- 1040-1047
- ISSN
- 0270-7306 (ISSN-L)
- 1098-5549
- OpenAlex
- W1856742644
- Cited by
- 123
- References
- 2
- FWCI
- 5.07
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.